Navigation Links
Tamoxifen May Offer Long-Term Heart, Cancer Protection
Date:3/22/2011

By Kathleen Doheny
HealthDay Reporter

TUESDAY, March 22 (HealthDay News) -- Taking the breast cancer drug tamoxifen for the recommended five years protects women from breast cancer recurrence better than a two-year course of the drug and it also shields some women from cardiovascular disease, new research finds.

The cancer protection and heart-disease risk reduction were noted 15 years after starting treatment, according to the study published online March 21 in the Journal of Clinical Oncology.

The findings may surprise many women on the medication, said Allan Hackshaw, deputy director of Cancer Research and the University College London Cancer Trials Center. "I think many women don't realize the benefits [reduced cancer recurrence] last a long time if they can complete the five-year course, and particularly also the CV [cardiovascular] disease benefit," he said.

Hackshaw and his colleagues studied follow-up data for 3,449 participants in the Cancer Research UK "Over 50s" trial comparing tamoxifen use of five years and two years by women with early beast cancer. The women were between 50 and 81 at the start.

During the initial study period, 1987 to 1997, the women took 20 milligrams of tamoxifen a day for two years. After that, they were assigned randomly to stop taking the drug or to continue taking tamoxifen for three more years, if they were recurrence-free.

The researchers then tracked cancer recurrences, new tumors, death and cardiovascular events through April 2010.

There were 1,103 recurrences, 755 deaths from breast cancer, 621 cardiovascular events and 236 deaths from cardiovascular events. They found that 15 years after the women first began taking tamoxifen, for every 100 who took it for five years, nearly six fewer women suffered a recurrence compared to those on the two-year regimen.

The longer treatment reduced the risk of breast cancer developing in the opposite bre
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Breast Cancer Drug Tamoxifen Saves Lives, Medical Costs: Study
2. Taking tamoxifen to prevent breast cancer can save lives and money
3. HOXB7 gene promotes tamoxifen resistance
4. Cough medicine could help doctors identify how breast cancer patients metabolize tamoxifen
5. Scientists reprogram triple-negative breast cancer cells to respond to tamoxifen
6. Gene Mutation Offers Clues to Tamoxifen-Blood Clot Link
7. Gene mutation increases thromboembolism risk in women taking tamoxifen
8. Cell study finds receptor can fight tamoxifen-resistant breast cancer cells
9. Raloxifene, Tamoxifen Both Guard Against Breast Cancer
10. Doctors must collaborate so that patients get full benefit of tamoxifen treatment
11. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tamoxifen May Offer Long-Term Heart, Cancer Protection
(Date:5/23/2013)... 24, 2013 Magnatag’s new magnetic 365-Day ... and reduces vacation conflicts. A Manufacturing Manager from Augusta ... conflicts; now employees and managers can check the board ... Attendance is important to us and the board makes ... may seem harsh but it has made a difference.” ...
(Date:5/23/2013)... Over the past decade, the traditional ... has affected the Medical Group Practice Management industry ... hours, more young physicians are opting out of private ... says IBISWorld industry analyst Anna Son. In addition, “faced ... of older physicians are selling their practices and moving ...
(Date:5/23/2013)... (PRWEB) May 24, 2013 Sublime ... Cellulite Whisperer line, with a 35% ... Summer Sale" includes two proprietary products, the ... Lotion . , Purchasers receive a report "Getting ... "The Gel has a wonderful grapefruit scent," says ...
(Date:5/23/2013)... HI (PRWEB) May 23, 2013 Magic often ... book describing the exploits of precocious twin five-year olds, Howie ... , is just such a case in point. May 23, ... and is timed to coincide with the start of ... experience combining family adventures, tons of amenities and, most precious ...
(Date:5/23/2013)... May 24, 2013 -- High blood glucose is associated ... intensive insulin therapy (IIT) to control hyperglycemia is a ... not show a consistent benefit and even shows harms ... American College of Physicians, (ACP) Clinical Guidelines Committee in ... American Journal of Medical Quality . , "Clinicians ...
Breaking Medicine News(10 mins):Health News:New Attendance, Vacation and Training Tracker Board Reduces Employee Conflicts and Improves Attendance 2Health News:Medical Group Practice Management in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Medical Group Practice Management in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Fresh Organics in the New Cellulite Whisperer® Products from Sublime Beauty®; "Get Ready for Summer Sale" Continues 2Health News:New Children's Comic Book, "Howie Goes to Maui," Launches May 23, 2013 On Four Seasons Resort Maui's Web Site 2Health News:New Children's Comic Book, "Howie Goes to Maui," Launches May 23, 2013 On Four Seasons Resort Maui's Web Site 3Health News:ACP issues recommendations for management of high blood glucose in hospitalized patients 2
... Colon cleansing is used widely for colonoscopic exploration ... (OSP) solution is the osmotic laxative most commonly ... OSP can induce severe hyperphosphatemia and hypocalcemia due ... been reports of deaths and irreversible dialysis-requiring renal ...
... is increasing worldwide and its prognosis is very ... for early detection and on surgical treatment for ... research team from China retrospectively evaluated 5311 liver ... and December 2003. Of these, 429 (8.1%) patients ...
... ... will be speaking at the McGuire Woods LLP "7th Annual Healthcare and Life ... 11, 2010 at the Palmer House Hilton in Chicago. Mr. Lynch will ... revenues in healthcare services. , ...
... ... The United States Department of Justice filed a complaint ... Johnson committed Medicaid fraud by paying Omnicare pharmacies kickbacks for recommending ... drugs. Omnicare is the largest pharmacy supplying drugs to nursing ...
... emergency department, federal report shows , THURSDAY, Jan. 14 ... million motor vehicle crash victims who had injuries ranging ... a new government study finds. , About 85 percent ... 321,000 were admitted or transferred to another acute care ...
... ... Scantronix’ Paper Medical Chart Conversions to all ePaperless Solutions’ EMR System Clients on the ... ... 15, 2010 -- Scantronix.net, an industry leader in electronic medical record (EMR) scanning, digitization ...
Cached Medicine News:Health News:Anesthesia Healthcare Partners CEO to Speak at Upcoming Healthcare Conference to Offer Insight on Managing Costs in Healthcare Services 2Health News:U.S. Department of Justice Alleges Johnson & Johnson Paid Kickbacks to Steer Nursing Home Prescriptions: Joins Chicago Pharmacist's Whistleblower Case 2Health News:U.S. Department of Justice Alleges Johnson & Johnson Paid Kickbacks to Steer Nursing Home Prescriptions: Joins Chicago Pharmacist's Whistleblower Case 3Health News:U.S. Department of Justice Alleges Johnson & Johnson Paid Kickbacks to Steer Nursing Home Prescriptions: Joins Chicago Pharmacist's Whistleblower Case 4Health News:U.S. Department of Justice Alleges Johnson & Johnson Paid Kickbacks to Steer Nursing Home Prescriptions: Joins Chicago Pharmacist's Whistleblower Case 5Health News:Scantronix and ePaperlessSolutions Form Key Partnership 2Health News:Scantronix and ePaperlessSolutions Form Key Partnership 3
(Date:5/24/2013)... England and BOSTON , ... GPCR drug discovery and development company, is pleased to announce that ... a Consultant to augment the Company,s business development capabilities in ... Usui has more than 15 years of experience in business development, ... at Perlegen Sciences, Inc., Roche Pharma ( Japan ), ...
(Date:5/23/2013)... , May 24, 2013 3SBio ... the "Company"), a leading China ... and marketing biopharmaceutical products, announced today that, at ... the Company,s shareholders voted in favor of the ... agreement and plan of merger dated February 8, ...
(Date:5/23/2013)... WASHINGTON , May 23, 2013  Vanda Pharmaceuticals Inc. ... company has been named the 2013 Life Science Firm of ... (TCM).  Vanda was honored at the TCM,s 25 ... Bethesda , Maryland.  The Tech Awards Celebration recognizes the ... in Maryland and the surrounding regions. ...
Breaking Medicine Technology:Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
... Oct. 29 /PRNewswire-FirstCall/ -- ... the global specialty biopharmaceutical company, announced today that it will ... INTUNIV (TM) (guanfacine) Extended Release Tablets, ... Daytrana ®( ) (methylphenidate transdermal system) CII, ...
... Matrox Graphics Inc., the leading manufacturer of specialized graphics ... the Matrox Xenia(TM) display controller boards ... workstations . The software suite contains a number ... including Radiology Information System (RIS), Picture Archiving and Communication ...
Cached Medicine Technology:Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30 2Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30 3Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30 4Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30 5Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30 6Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30 7Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30 8Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30 9Rogan-Delft Approves Matrox Xenia Series for Use With Zillion Suite 2Rogan-Delft Approves Matrox Xenia Series for Use With Zillion Suite 3
... a fully automated genetic analysis system. This ... a patented linear polyacrylamide (LPA) gel, denatures ... program, and analyzes the data. Software tools ... even customize automated data assessment. All to ...
Basic critical care testing. Measures pH, pCO2, and pO2 from 85 L whole-blood sample....
... Measures up to 17 parameters ... blood: pH and blood gases, as ... bilirubin, electrolyte, and metabolite parameters. Unique ... interfering effect some substances have on ...
348 is fully automated blood gas systems offering a cost-effective solution for critical care testing in settings with low to medium workloads....
Medicine Products: